Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 2 Subgroup analysis: arthritic progression and patient characteristics
Group | Arthritic progression | No arthritic progression | p-Value |
|---|---|---|---|
Age at follow-up (years) | 58.3 (± 8.052) | 62.4 (± 6.58) | 0.4417 (n.s.) |
Gender (F/M ratio) | 0.80/0.20 | 0.40/0.60 | 0.0946 (n.s.) |
BMI (kg/m2) | 24.09 (22.15–25.28) | 23.71 (22.27–25.46) | 0.9545 (n.s.) |
Follow-up (years) | 12.00 (12.00–15.25) | 14 (12.50–15.50) | 0.6928 (n.s.) |
Dominant side (L/R ratio) | 0.10/0.90 | 0.40/0.60 | 0.2379 (n.s.) |
Affected side (L/R ratio) | 0.40/0.60 | 0.40/0.60 | 1.0000 (n.s.) |
Smoker at follow-up (Y/N ratio) | 0.33/0.67 | 0.20/0.80 | 1.0000 (n.s.) |
Smoker at diagnosis (Y/N ratio) | 0.37/0.63 | 0.60/0.40 | 0.3691 (n.s.) |
Diabetes (Y/N ratio) | 0.03/0.97 | 0.00/1 | 1.0000 (n.s.) |
Job (light/hard) | 0.57/0.43 | 0.80/0.20 | 0.6272 (n.s.) |
Autoimmune disease (Y/N ratio) | 0.23/0.77 | 0.40/0.60 | 0.5908 (n.s.) |